A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.
“I use Manjaro BTW”
(“I use Manjaro, please don’t bully me or ask me to use the terminal. Also, why hasn’t Manjaro renewed their SSL certificate?”)